Recent Updates
Recently added Catalysts
RLAY Positive Sentiment

Relay Therapeutics to Participate in Upcoming Investor Conferences

Thursday, November 7, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Relay Therapeutics, a clinical-stage precision medicine company, has announced its participation in several upcoming investor conferences. This includes the Guggenheim Healthcare Innovation Conference, Stifel 2024 Healthcare Conference, Jefferies London Healthcare Conference, and the Citizens JMP Hematology and Oncology Summit. Management's participation highlights their commitment to engaging with investors and promoting their innovative approach to drug discovery. The events will be webcast live, indicating a focus on transparency and communication.
Price reaction · baseline $6.25 (2024-11-06 close) · hit after-hours · clean, no other RLAY news in the window
day 0 close · peak
-1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Relay Therapeutics is engaging with investors through multiple conferences.
  • Participation in high-profile events indicates confidence in their programs.
  • Live webcasts provide accessibility, enhancing investor relations.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+284%
120-day peak, hindsight
Typical move
11.8%
average across 6 past catalysts
Cash runway
~50 mo
Minimal dilution risk
Lead asset
RLY-8161
Phase 1 · Advanced NRAS-Mutant Melanoma

Full Press Release Details

CAMBRIDGE, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in the following upcoming fireside chats:
Guggenheim Healthcare Innovation Conference on Wednesday, November 13, 2024 at 10:00 a.m. ET
Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 10:55 a.m. ET
Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 6:30 a.m. ET (11:30 a.m. GMT)
The Citizens JMP Hematology and Oncology Summit, taking place virtually on Monday, December 2, 2024 at 1:30 p.m. ET
The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.
About Relay Therapeutics

Frequently Asked Questions

When is the Guggenheim Healthcare Conference scheduled?

The Guggenheim Healthcare Innovation Conference will be on November 13, 2024, at 10:00 a.m. ET.

What is the date for the Stifel Healthcare Conference?

The Stifel 2024 Healthcare Conference is set for November 18, 2024, at 10:55 a.m. ET.

When will the Jefferies London Healthcare Conference take place?

The Jefferies London Healthcare Conference is on November 20, 2024, at 6:30 a.m. ET.

What time is the Citizens JMP Summit?

The Citizens JMP Hematology and Oncology Summit occurs on December 2, 2024, at 1:30 p.m. ET.

Where can I access the live webcasts of the events?

Live webcasts can be accessed on Relay Therapeutics’ website under the Events section.

ShareAdd on Google
Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics investor conferences drug discovery healthcare events
Last updated: Nov 7, 2024

Biotech snapshot

Cash runway
$911M liquidity · $18M/mo burn
~50 mo
Minimal dilution risk
Lead asset
RLY-8161Phase 1
Advanced NRAS-Mutant Melanoma →

Catalyst track record

+284%
best trade around RLAY's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for RLAY.

See every catalyst's timing & PoA →